Cytochrome P450 Polymorphisms as Risk Factors for Steroid Hormone-Related Cancers

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.1, Iss.2, 2001-01, pp. : 83-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric Legendre Christopher Beaune Philippe Anglicheau Dany

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and response to antipsychotic therapy

By Scordo Maria Gabriella Spina Edoardo

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 201-218

Future Medicine

Access to resources Recommend Favorite

Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers

Current Drug Metabolism, Vol. 16, Iss. 10, 2015-12 ,pp. : 850-863

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

By Porcelli Stefano Fabbri Chiara Spina Edoardo Serretti Alessandro De Ronchi Diana

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1101-1115

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin Behr Werner Foerg Wolfgang Berghaus Thomas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite